Singapore: Eisai revealed its preliminary results from a recently completed phase III study of Halaven versus capecitabi...
Singapore: A study by researchers at the University of Michigan Medical School, US, found that antidepressant drug trany...
Singapore: Australian pharmaceutical company Pharmaxis is all set to launch Bronchitol for cystic fibrosis (CF) patients...
Singapore: UK's Marvel LifeScience, insulin marketing company, has withdrawn its application for centralized marketing a...
Singapore: Alchemia has completed enrollment of patients in a pivotal phase III clinical trial evaluating its lead prod...
Sinapore: Bayer HealthCare in Singapore in collaboration with five research institutions have kaunched new Integrated Tr...
Singapore: Daiichi Sankyo's 24-month randomized, double-blind, placebo-controlled multi-center phase III clinical trial ...
Singapore: Gilead Sciences plans to halt phase III study evaluating idelalisib in previously-treated chronic lymphocytic...
Singapore: Sihuan Pharmaceutical entered into a collaboration agreement with NeuroVive Pharmaceutical to develop two in...
Singapore: Australian company Bioxyne closed its 320-patient study, which was designed to evaluate the efficacy and safe...
Singapore: MicuRx Pharmaceuticals, a privately-held biopharmaceutical company developing next-generation antibiotics, ha...
Singapore: MedImmune, the global biologics R&D arm of AstraZeneca, has entered into a three-year collaboration with ...
Singapore: Belgium based pharmaceutical company UCB and global pharmaceutical company, Biogen, have entered into an agre...
Singapore: BD Biosciences, a global medical technology company, has launched BD LSRFortessa X-20 Cell Analyzer, to deliv...
Singapore: Assistant Professor (Dr) Robert H I Andtbacka presented a summary of his ongoing study with Viralytics' Cavat...
Singapore: India-based Orchid Pharma entered into a strategic partnership with Europe-based Allecra Therapeutics to deve...
Singapore: CoDa Therapeutics has raised an additional $19.8 million (NZ$24.5 million) from Russian investment firm Rusna...
Singapore: Japanese multinational Chugai Pharmaceutical has filed a new drug application to the Ministry of Health, Labo...
